Endo's HIV gel disappoints, but should turn up the heat for alternatives like Starpharma

December 15, 2009 | Analyst Insight

According to an announcement by Britain's Medical Research Council (MRC), Endo Pharmaceutical's Pro 2000 gel, meant to prevent the spread of AIDS, was "definitively" shown to be ineffective in clinical trials...

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978